IEG Policy is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Gottlieb fields questions about CBD, dairy terms, cell-based meat at Senate hearing

This article is powered by Food Chemical News

From the labeling and testing of cell-based meats to FDA’s plans for CBD products and the appropriate terminology for plant-based ‘dairy’ products, a number of high-profile food issues surfaced on Thursday (March 28) as Scott Gottlieb testified at one of his last budget hearings as FDA commissioner.


Related Content

Genetic testing could help regulators in crafting a regulatory path for CBD
FDA sheds light on requested $38.4 million increase for FY 2020 food programs
FDA, USDA sign MOU to jointly oversee cell-based meat
FDA Commissioner Scott Gottlieb to resign


What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts